Epirubicin/idarubicinAcute lymphoblastic leukaemia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1559卷 / 1期

关键词：

D O I：

10.1007/s40278-015-3260-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[21] Multiple drugsDevelopement of resistance in acute lymphoblastic leukaemia: 3 case reports
Reactions Weekly, 2020, 1794 (1) : 164 - 164
[22] Cisplatin/epirubicin/paclitaxelVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1706 (1) : 135 - 135
[23] Cisplatin/epirubicin/paclitaxelVarious toxicities: 2 case reports
Reactions Weekly, 2016, 1622 (1) : 65 - 65
[24] Epirubicin/Ifosfamide/SorafenibLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 600 - 600
[25] AntineoplasticsAcute lymphoblastic leukaemia (first report with bleomycin and cytarabine) and fatal acute myelomonocytic leukaemia (first report with cytarabine): 2 case reports
Reactions Weekly, 2009, 1238 (1) : 5 - 5
[26] MitoxantroneAcute myeloblastic leukaemia: 2 case reports
Reactions Weekly, 2011, 1340 (1) : 29 - 29
[27] MitoxantroneAcute myeloid leukaemia: 2 case reports
Reactions Weekly, 2008, 1204 (1) : 23 - 23
[28] AntineoplasticsAcute myeloid leukaemia: 2 case reports
Reactions Weekly, 2020, 1813 (1) : 37 - 37
[29] AntineoplasticsAcute myeloid leukaemia: 2 case reports
Reactions Weekly, 2017, 1672 (1) : 32 - 32
[30] MitoxantroneAcute promyelocytic leukaemia: 2 case reports
Reactions Weekly, 2007, 1135 (1) : 23 - 23

← 1 2 3 4 5 →